- Home
- VNDA vs TSSI Comparison
VNDA vs TSSI Comparison
Compare VNDA & TSSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- TSSI
- Stock Information
- Founded
- VNDA 2002
- TSSI 2004
- Country
- VNDA United States
- TSSI United States
- Employees
- VNDA N/A
- TSSI N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- TSSI Professional Services
- Sector
- VNDA Health Care
- TSSI Consumer Discretionary
- Exchange
- VNDA Nasdaq
- TSSI Nasdaq
- Market Cap
- VNDA 237.9M
- TSSI 221.9M
- IPO Year
- VNDA 2006
- TSSI N/A
- Fundamental
- Price
- VNDA $4.34
- TSSI $14.44
- Analyst Decision
- VNDA Strong Buy
- TSSI
- Analyst Count
- VNDA 3
- TSSI 0
- Target Price
- VNDA $15.33
- TSSI N/A
- AVG Volume (30 Days)
- VNDA 519.0K
- TSSI 3.5M
- Earning Date
- VNDA 05-07-2025
- TSSI 05-15-2025
- Dividend Yield
- VNDA N/A
- TSSI N/A
- EPS Growth
- VNDA N/A
- TSSI 770.13
- EPS
- VNDA N/A
- TSSI 0.35
- Revenue
- VNDA $201,351,000.00
- TSSI $231,211,000.00
- Revenue This Year
- VNDA $16.86
- TSSI N/A
- Revenue Next Year
- VNDA $39.78
- TSSI N/A
- P/E Ratio
- VNDA N/A
- TSSI $41.14
- Revenue Growth
- VNDA 13.37
- TSSI 262.87
- 52 Week Low
- VNDA $3.81
- TSSI $1.48
- 52 Week High
- VNDA $6.75
- TSSI $18.26
- Technical
- Relative Strength Index (RSI)
- VNDA 51.79
- TSSI N/A
- Support Level
- VNDA $4.17
- TSSI N/A
- Resistance Level
- VNDA $4.41
- TSSI N/A
- Average True Range (ATR)
- VNDA 0.16
- TSSI 0.00
- MACD
- VNDA 0.03
- TSSI 0.00
- Stochastic Oscillator
- VNDA 73.61
- TSSI 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About TSSI TSS Inc. Common Stock
TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.